These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 15450815

  • 1. An in vitro screening assay based on synthetic prion protein peptides for identification of fibril-interfering compounds.
    Boshuizen RS, Langeveld JP, Salmona M, Williams A, Meloen RH, Langedijk JP.
    Anal Biochem; 2004 Oct 15; 333(2):372-80. PubMed ID: 15450815
    [Abstract] [Full Text] [Related]

  • 2. Polyanion induced fibril growth enables the development of a reproducible assay in solution for the screening of fibril interfering compounds, and the investigation of the prion nucleation site.
    Boshuizen RS, Morbin M, Mazzoleni G, Tagliavini F, Meloen RH, Langedijk JP.
    Amyloid; 2007 Sep 15; 14(3):205-19. PubMed ID: 17701468
    [Abstract] [Full Text] [Related]

  • 3. Copper(II) inhibits in vitro conversion of prion protein into amyloid fibrils.
    Bocharova OV, Breydo L, Salnikov VV, Baskakov IV.
    Biochemistry; 2005 May 10; 44(18):6776-87. PubMed ID: 15865423
    [Abstract] [Full Text] [Related]

  • 4. Molecular interactions of dendrimers with amyloid peptides: pH dependence.
    Klajnert B, Cladera J, Bryszewska M.
    Biomacromolecules; 2006 Jul 10; 7(7):2186-91. PubMed ID: 16827586
    [Abstract] [Full Text] [Related]

  • 5. Highly accelerated self-assembly and fibrillation of prion peptides on solid surfaces.
    Ku SH, Park CB.
    Langmuir; 2008 Dec 16; 24(24):13822-7. PubMed ID: 19053635
    [Abstract] [Full Text] [Related]

  • 6. Linear quantitation of Abeta aggregation using Thioflavin T: reduction in fibril formation by colostrinin.
    Bourhim M, Kruzel M, Srikrishnan T, Nicotera T.
    J Neurosci Methods; 2007 Mar 15; 160(2):264-8. PubMed ID: 17049613
    [Abstract] [Full Text] [Related]

  • 7. Influence of phosphorus dendrimers on the aggregation of the prion peptide PrP 185-208.
    Klajnert B, Cortijo-Arellano M, Cladera J, Majoral JP, Caminade AM, Bryszewska M.
    Biochem Biophys Res Commun; 2007 Dec 07; 364(1):20-5. PubMed ID: 17927954
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of fibril formation in beta-amyloid peptide by a novel series of benzofurans.
    Howlett DR, Perry AE, Godfrey F, Swatton JE, Jennings KH, Spitzfaden C, Wadsworth H, Wood SJ, Markwell RE.
    Biochem J; 1999 May 15; 340 ( Pt 1)(Pt 1):283-9. PubMed ID: 10229684
    [Abstract] [Full Text] [Related]

  • 9. In vitro conversion of mammalian prion protein into amyloid fibrils displays unusual features.
    Baskakov IV, Bocharova OV.
    Biochemistry; 2005 Feb 22; 44(7):2339-48. PubMed ID: 15709746
    [Abstract] [Full Text] [Related]

  • 10. Influence of dendrimer's structure on its activity against amyloid fibril formation.
    Klajnert B, Cortijo-Arellano M, Cladera J, Bryszewska M.
    Biochem Biophys Res Commun; 2006 Jun 23; 345(1):21-8. PubMed ID: 16674918
    [Abstract] [Full Text] [Related]

  • 11. Amyloid aggregates of the prion peptide PrP106-126 are destabilised by oxidation and by the action of dendrimers.
    Heegaard PM, Pedersen HG, Flink J, Boas U.
    FEBS Lett; 2004 Nov 05; 577(1-2):127-33. PubMed ID: 15527773
    [Abstract] [Full Text] [Related]

  • 12. Peptide NMHRYPNQ of the cellular prion protein (PrP(C)) inhibits aggregation and is a potential key for understanding prion-prion interactions.
    Rehders D, Claasen B, Redecke L, Buschke A, Reibe C, Jehmlich N, von Bergen M, Betzel C, Meyer B.
    J Mol Biol; 2009 Sep 11; 392(1):198-207. PubMed ID: 19607841
    [Abstract] [Full Text] [Related]

  • 13. Inhibitory effect of minocycline on amyloid beta fibril formation and human microglial activation.
    Familian A, Boshuizen RS, Eikelenboom P, Veerhuis R.
    Glia; 2006 Feb 11; 53(3):233-40. PubMed ID: 16220550
    [Abstract] [Full Text] [Related]

  • 14. Using budding yeast to screen for anti-prion drugs.
    Tribouillard D, Bach S, Gug F, Desban N, Beringue V, Andrieu T, Dormont D, Galons H, Laude H, Vilette D, Blondel M.
    Biotechnol J; 2006 Jan 11; 1(1):58-67. PubMed ID: 16892225
    [Abstract] [Full Text] [Related]

  • 15. A molecular dynamics approach to the structural characterization of amyloid aggregation.
    Cecchini M, Curcio R, Pappalardo M, Melki R, Caflisch A.
    J Mol Biol; 2006 Apr 07; 357(4):1306-21. PubMed ID: 16483608
    [Abstract] [Full Text] [Related]

  • 16. Activation of human microglia by fibrillar prion protein-related peptides is enhanced by amyloid-associated factors SAP and C1q.
    Veerhuis R, Boshuizen RS, Morbin M, Mazzoleni G, Hoozemans JJ, Langedijk JP, Tagliavini F, Langeveld JP, Eikelenboom P.
    Neurobiol Dis; 2005 Apr 07; 19(1-2):273-82. PubMed ID: 15837583
    [Abstract] [Full Text] [Related]

  • 17. Core structure of amyloid fibrils formed by residues 106-126 of the human prion protein.
    Walsh P, Simonetti K, Sharpe S.
    Structure; 2009 Mar 11; 17(3):417-26. PubMed ID: 19278656
    [Abstract] [Full Text] [Related]

  • 18. Design, selection, and characterization of thioflavin-based intercalation compounds with metal chelating properties for application in Alzheimer's disease.
    Rodríguez-Rodríguez C, Sánchez de Groot N, Rimola A, Alvarez-Larena A, Lloveras V, Vidal-Gancedo J, Ventura S, Vendrell J, Sodupe M, González-Duarte P.
    J Am Chem Soc; 2009 Feb 04; 131(4):1436-51. PubMed ID: 19133767
    [Abstract] [Full Text] [Related]

  • 19. Detection of misfolded prion protein in blood with conformationally sensitive peptides.
    Pan T, Sethi J, Nelsen C, Rudolph A, Cervenakova L, Brown P, Orser CS.
    Transfusion; 2007 Aug 04; 47(8):1418-25. PubMed ID: 17655586
    [Abstract] [Full Text] [Related]

  • 20. Protein denaturation and aggregation: Cellular responses to denatured and aggregated proteins.
    Meredith SC.
    Ann N Y Acad Sci; 2005 Dec 04; 1066():181-221. PubMed ID: 16533927
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.